Ossur hf. divests its Advanced Wound Care product line

3/31/2008, 5:53 PM (Source: GlobeNewswire)
Ossur hf. (OMX: OSSR), a leading global supplier of non-invasive
orthopaedic devices, has divested its Advanced Wound Care product
line to BSN medical GmbH, a leading global provider of wound care
products.

The divestiture strengthens Ossur's focus on the vast opportunities
in the Company's core business segments.

The transaction, which closed today, is valued at USD 11 million.
Subject to certain conditions, the transaction value could further
increase by up to USD 6 million. As previously disclosed, Ossur is
involved in intellectual property litigation related to the Advanced
Wound Care product line. The Company will retain responsibility for
these. Part of the transaction value is reserved for covering future
litigation expense exposure.

Net sales gain recorded as other income in the first quarter of 2008
will be approximately USD 5.5 million.



About Ossur:
Ossur (OMX: OSSR) is a global leader in non-invasive orthopaedics
that help people live a life without limitations. Its business is
focused on improving people's mobility through the delivery of
innovative technologies within the fields of braces, supports,
prosthetic limbs and compression therapy. A recognized "Technology
Pioneer", Ossur invests significantly in research and product
development; its award-winning designs ensuring a consistently strong
position in the market. Successful patient and clinical outcomes are
further empowered via Ossur's educational programs and business
solutions. Headquartered in Iceland, Ossur has major operations in
the Americas, Europe and Asia, with additional distributors
worldwide.

About BSN medical:
BSN medical is a global leader in the worldwide healthcare market
specializing in the areas of Fracture Management, Physiotheraphy,
Lymphology, Phlebology and wound care. BSN is focused on the
development of world-class branded products that offer high quality
solutions for its caregivers and patients. BSN medical was originally
formed as a joint venture in 2001 between Beiersdorf and Smith &
Nephew. In 2006, BSN medical became a fully independent player in the
Wound Care, Orthopaedics and Phlebology segments. It was acquired by
funds advised by Montagu Private Equity, a leading European private
company established in 1968. With its headquarter located in Germany,
it has major operations in Europe, in the Americas and Asia and
operates via joint-ventures and distributors in other regions.
Copyright GlobeNewswire, Inc. 2016. All rights reserved.
You can register yourself on the website to receive press releases directly via e-mail to your own e-mail account.